Catheter Precision, Inc.VTAK

$0.84-0.11 (-11.58%)
AMEXHealthcare24:00 UTC

Company snapshot

Market Cap
$2B
Small-cap
-95%
2018 — today
10-Year Price
-100%
2018 — today
52-Week Range
$0.76$5.11
Current $0.84· 2%

Catheter Precision, Inc., headquartered in Fort Mill, South Carolina, is dedicated to creating and distributing electrophysiology products. Their mission is to enhance treatment and outcomes for U.S. patients suffering from cardiac arrhythmias by providing innovative technologies and solutions to patients, hospitals, and physicians. Their premier product, the View into Ventricular Onset System (VIVO), is a non-invasive 3D cardiac mapping solution designed to accurately locate the origin points of idiopathic ventricular arrhythmias in patients with otherwise healthy hearts, before they undergo electrophysiology procedures. Additionally, they offer LockeT, a device for suture retention, and the Amigo Remote Catheter System, a robotic arm used for precise catheter control. The company, previously known as Ra Medical Systems, Inc., officially adopted the name Catheter Precision, Inc. in August 2023.

Valuation in context

P/E ratio
-0.1
N/A
Not meaningful — company is unprofitable
P/B ratio
201.1
Historically pricey
Historically pricey — last 10 years
FCF Yield
-0.5%
Historically high
Historically high relative to the last 10 years
Free · No credit card needed

Get alerted when VTAK is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.